vs

Side-by-side financial comparison of Biofrontera Inc. (BFRI) and Legacy Education Inc. (LGCY). Click either name above to swap in a different company.

Legacy Education Inc. is the larger business by last-quarter revenue ($19.2M vs $17.1M, roughly 1.1× Biofrontera Inc.). Biofrontera Inc. runs the higher net margin — 33.0% vs 10.6%, a 22.3% gap on every dollar of revenue. On growth, Legacy Education Inc. posted the faster year-over-year revenue change (40.7% vs 36.2%). Legacy Education Inc. produced more free cash flow last quarter ($512.7K vs $-2.4M).

Biofrontera Inc. is a specialty biopharmaceutical enterprise focused on developing and commercializing prescription dermatological products. Its core product line targets skin conditions including actinic keratosis and other dermatological disorders, with primary operating markets in the United States and European Union, serving patients and dermatology care providers.

Legacy Education Inc. is a professional educational service provider focused on financial literacy, real estate investment, entrepreneurship, and personal wealth management training programs. It mainly serves individual learners across North America, Europe and select Asia-Pacific markets, offering both in-person workshops and online digital courses to help users build practical financial and business skills.

BFRI vs LGCY — Head-to-Head

Bigger by revenue
LGCY
LGCY
1.1× larger
LGCY
$19.2M
$17.1M
BFRI
Growing faster (revenue YoY)
LGCY
LGCY
+4.5% gap
LGCY
40.7%
36.2%
BFRI
Higher net margin
BFRI
BFRI
22.3% more per $
BFRI
33.0%
10.6%
LGCY
More free cash flow
LGCY
LGCY
$2.9M more FCF
LGCY
$512.7K
$-2.4M
BFRI

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
BFRI
BFRI
LGCY
LGCY
Revenue
$17.1M
$19.2M
Net Profit
$5.6M
$2.0M
Gross Margin
Operating Margin
26.6%
13.3%
Net Margin
33.0%
10.6%
Revenue YoY
36.2%
40.7%
Net Profit YoY
504.0%
46.0%
EPS (diluted)
$0.62
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFRI
BFRI
LGCY
LGCY
Q4 25
$17.1M
$19.2M
Q3 25
$7.0M
$19.4M
Q2 25
$9.0M
$18.0M
Q1 25
$8.6M
$18.6M
Q4 24
$12.6M
$13.6M
Q3 24
$9.0M
$14.0M
Q2 24
$7.8M
Q1 24
$7.9M
Net Profit
BFRI
BFRI
LGCY
LGCY
Q4 25
$5.6M
$2.0M
Q3 25
$-6.6M
$2.2M
Q2 25
$-5.3M
$1.2M
Q1 25
$-4.2M
$2.8M
Q4 24
$-1.4M
$1.4M
Q3 24
$-5.7M
$2.1M
Q2 24
$-257.0K
Q1 24
$-10.4M
Operating Margin
BFRI
BFRI
LGCY
LGCY
Q4 25
26.6%
13.3%
Q3 25
-89.8%
13.9%
Q2 25
-56.2%
11.1%
Q1 25
-52.9%
19.7%
Q4 24
-13.6%
12.2%
Q3 24
-55.0%
19.1%
Q2 24
-64.7%
Q1 24
-69.1%
Net Margin
BFRI
BFRI
LGCY
LGCY
Q4 25
33.0%
10.6%
Q3 25
-95.1%
11.3%
Q2 25
-59.0%
6.8%
Q1 25
-48.9%
15.2%
Q4 24
-11.1%
10.3%
Q3 24
-62.9%
14.9%
Q2 24
-3.3%
Q1 24
-131.9%
EPS (diluted)
BFRI
BFRI
LGCY
LGCY
Q4 25
$0.62
$0.15
Q3 25
$-0.62
$0.16
Q2 25
$-0.57
$0.07
Q1 25
$-0.47
$0.21
Q4 24
$0.69
$0.10
Q3 24
$-0.98
$0.21
Q2 24
$-0.05
Q1 24
$-2.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFRI
BFRI
LGCY
LGCY
Cash + ST InvestmentsLiquidity on hand
$6.4M
$21.1M
Total DebtLower is stronger
$660.3K
Stockholders' EquityBook value
$10.5M
$46.1M
Total Assets
$28.6M
$73.1M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFRI
BFRI
LGCY
LGCY
Q4 25
$6.4M
$21.1M
Q3 25
$3.4M
$20.6M
Q2 25
$7.2M
$20.3M
Q1 25
$1.8M
$17.3M
Q4 24
$5.9M
$16.9M
Q3 24
$2.9M
$21.5M
Q2 24
$4.4M
Q1 24
$3.8M
Total Debt
BFRI
BFRI
LGCY
LGCY
Q4 25
$660.3K
Q3 25
$776.9K
Q2 25
$1.4M
Q1 25
$1.0M
Q4 24
$1.1M
Q3 24
$758.2K
Q2 24
Q1 24
Stockholders' Equity
BFRI
BFRI
LGCY
LGCY
Q4 25
$10.5M
$46.1M
Q3 25
$-2.6M
$43.7M
Q2 25
$-4.7M
$41.0M
Q1 25
$500.0K
$39.3M
Q4 24
$4.4M
$36.4M
Q3 24
$5.5M
$32.6M
Q2 24
$10.9M
Q1 24
$-5.4M
Total Assets
BFRI
BFRI
LGCY
LGCY
Q4 25
$28.6M
$73.1M
Q3 25
$15.4M
$72.1M
Q2 25
$20.1M
$69.2M
Q1 25
$16.6M
$67.1M
Q4 24
$22.1M
$62.1M
Q3 24
$18.5M
$50.6M
Q2 24
$21.6M
Q1 24
$24.6M
Debt / Equity
BFRI
BFRI
LGCY
LGCY
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.02×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFRI
BFRI
LGCY
LGCY
Operating Cash FlowLast quarter
$-2.4M
$1.1M
Free Cash FlowOCF − Capex
$-2.4M
$512.7K
FCF MarginFCF / Revenue
-13.9%
2.7%
Capex IntensityCapex / Revenue
0.0%
2.8%
Cash ConversionOCF / Net Profit
-0.42×
0.52×
TTM Free Cash FlowTrailing 4 quarters
$-13.4M
$4.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFRI
BFRI
LGCY
LGCY
Q4 25
$-2.4M
$1.1M
Q3 25
$-3.8M
$1.1M
Q2 25
$-3.0M
$3.0M
Q1 25
$-4.1M
$918.7K
Q4 24
$-1.0M
$659.0K
Q3 24
$-1.2M
$3.2M
Q2 24
$-4.7M
Q1 24
$-3.3M
Free Cash Flow
BFRI
BFRI
LGCY
LGCY
Q4 25
$-2.4M
$512.7K
Q3 25
$-3.8M
$809.7K
Q2 25
$-3.0M
$2.9M
Q1 25
$-4.1M
$596.6K
Q4 24
$-1.0M
$466.8K
Q3 24
$2.9M
Q2 24
$-4.8M
Q1 24
$-3.4M
FCF Margin
BFRI
BFRI
LGCY
LGCY
Q4 25
-13.9%
2.7%
Q3 25
-54.7%
4.2%
Q2 25
-33.7%
16.2%
Q1 25
-48.0%
3.2%
Q4 24
-8.1%
3.4%
Q3 24
21.1%
Q2 24
-60.8%
Q1 24
-42.7%
Capex Intensity
BFRI
BFRI
LGCY
LGCY
Q4 25
0.0%
2.8%
Q3 25
0.0%
1.3%
Q2 25
0.0%
0.5%
Q1 25
0.0%
1.7%
Q4 24
0.0%
1.4%
Q3 24
0.0%
1.7%
Q2 24
0.6%
Q1 24
0.7%
Cash Conversion
BFRI
BFRI
LGCY
LGCY
Q4 25
-0.42×
0.52×
Q3 25
0.48×
Q2 25
2.45×
Q1 25
0.33×
Q4 24
0.47×
Q3 24
1.52×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons